Revenue expenditure, transfer pricing consistency and warranty provisions were treated as allowable on the facts considered.

Product development expenses incurred for repeated testing, validation and improvement of existing products were treated as revenue expenditure because they did not create a new asset or product and formed part of the regular business process. Transfer pricing adjustment was held to be confined to international transactions with associated enterprises, and margins under TNMM had to be computed on a consistent operating-cost and operating-revenue base for both the assessee and comparables. Unsuitable public sector comparables were excluded, risk adjustment was recognised for a captive service provider, leased line cost allocation based on consistent usage was accepted, and a comparable rejected for lack of public data was to be verified. A warranty provision made on a scientific basis against an existing business liability was allowable as a deduction.

---

---

Issues: (i) Whether product development expenses incurred for testing, validation and improvisation of existing products were revenue expenditure. (ii) Whether transfer pricing adjustment had to be confined to international transactions with associated enterprises and whether operating margins were to be computed by applying the same operating-cost base and operating-revenue items to the assessee and comparables. (iii) Whether the assessee was entitled to exclusion of unsuitable comparables, risk adjustment, proper allocation of leased line cost, and verification of a comparable rejected for want of public data. (iv) Whether the provision made for warranty liability was allowable as a deduction.

Issue (i): Whether product development expenses incurred for testing, validation and improvisation of existing products were revenue expenditure.

Analysis: The expenditure was incurred repeatedly for testing and validation of products already being manufactured, to improve suitability and meet customer requirements. It did not result in acquisition or creation of an asset, nor did it bring into existence a new product. The nature of the bills and the recurring character of the exercise supported treatment as part of the normal business process rather than capital development.

Conclusion: The expenditure was allowable as revenue expenditure and the disallowance was not sustained.

Issue (ii): Whether transfer pricing adjustment had to be confined to international transactions with associated enterprises and whether operating margins were to be computed by applying the same operating-cost base and operating-revenue items to the assessee and comparables.

Analysis: Transfer pricing adjustment under the relevant provisions is confined to transactions with associated enterprises and cannot be expanded to non-AE turnover merely because segmental accounts are absent. For benchmarking under TNMM, depreciation, duty drawback and scrap sales, being part of operating results on the facts found, had to be consistently reflected in the assessee's figures and in the comparable companies' figures. The same method had to be applied on both sides to avoid an uneven comparison.

Conclusion: The adjustment was required to be restricted to AE transactions, and the operating margins were to be recomputed on a consistent basis.

Issue (iii): Whether the assessee was entitled to exclusion of unsuitable comparables, risk adjustment, proper allocation of leased line cost, and verification of a comparable rejected for want of public data.

Analysis: Public sector and government enterprises with distinct functions, social obligations and risk profiles were not comparable to a captive service provider. Where the assessee bore a limited risk profile, risk adjustment was justified. Leased line cost could not be apportioned on an ad hoc basis when a consistent usage-based allocation was followed. A comparable rejected for non-availability of public information required verification where data was stated to be available in the database relied upon.

Conclusion: The selected public sector comparables were to be excluded, risk adjustment was to be allowed, the leased line cost allocation was to be accepted on the basis adopted by the assessee, and the rejected comparable issue was remitted for verification.

Issue (iv): Whether the provision made for warranty liability was allowable as a deduction.

Analysis: A provision for warranty made on a scientific and consistent basis, backed by past experience and matched with actual expenditure when incurred, is not a mere contingent liability. The facts showed a regular business liability arising from sales made by the assessee, and the provision answered the settled test for allowability.

Conclusion: The warranty provision was allowable and the disallowance was deleted.

Final Conclusion: The Revenue's appeals failed, while the assessee obtained relief on the transfer pricing and warranty issues, resulting in only partial success for the assessee overall.

Ratio Decidendi: A recurring business expenditure incurred for testing and improvement of existing products is revenue in nature; transfer pricing adjustment must be confined to AE transactions and benchmarked on a consistent operating base; and a warranty provision made on a scientific basis for an existing business liability is allowable.

---